[go: up one dir, main page]

AU2001296554A1 - Fluorescence detection - Google Patents

Fluorescence detection

Info

Publication number
AU2001296554A1
AU2001296554A1 AU2001296554A AU9655401A AU2001296554A1 AU 2001296554 A1 AU2001296554 A1 AU 2001296554A1 AU 2001296554 A AU2001296554 A AU 2001296554A AU 9655401 A AU9655401 A AU 9655401A AU 2001296554 A1 AU2001296554 A1 AU 2001296554A1
Authority
AU
Australia
Prior art keywords
fluorescence detection
fluorescence
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001296554A
Inventor
Miguel E. Carrion
Marilyn Menger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genvec Inc
Original Assignee
Genvec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genvec Inc filed Critical Genvec Inc
Publication of AU2001296554A1 publication Critical patent/AU2001296554A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
AU2001296554A 2000-10-04 2001-10-04 Fluorescence detection Abandoned AU2001296554A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/679,439 2000-10-04
US09/679,439 US6447995B1 (en) 2000-10-04 2000-10-04 Utilizing intrinsic fluorescence to detect adenovirus
PCT/US2001/030980 WO2002029388A2 (en) 2000-10-04 2001-10-04 Fluorescence detection

Publications (1)

Publication Number Publication Date
AU2001296554A1 true AU2001296554A1 (en) 2002-04-15

Family

ID=24726913

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001296554A Abandoned AU2001296554A1 (en) 2000-10-04 2001-10-04 Fluorescence detection

Country Status (4)

Country Link
US (2) US6447995B1 (en)
EP (1) EP1322938A2 (en)
AU (1) AU2001296554A1 (en)
WO (1) WO2002029388A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0968284B1 (en) * 1996-11-20 2006-12-13 Introgen Therapeutics, Inc. An improved method for the production and purification of adenoviral vectors
US7732129B1 (en) * 1998-12-01 2010-06-08 Crucell Holland B.V. Method for the production and purification of adenoviral vectors
US20030224354A1 (en) * 2002-05-30 2003-12-04 Introgen Therapeutics Inc. Quantifying viral particles with intrinsic fluorescence
WO2004068104A2 (en) * 2003-01-24 2004-08-12 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target activated microtransfer
US7695752B2 (en) * 2003-01-24 2010-04-13 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target activated microtransfer
US20040166091A1 (en) * 2003-02-24 2004-08-26 Genvec, Inc. Materials and methods for treating disorders of the ear
US7060992B1 (en) 2003-03-10 2006-06-13 Tiax Llc System and method for bioaerosol discrimination by time-resolved fluorescence
ES2391975T3 (en) * 2003-07-25 2012-12-03 Genvec, Inc. Adenoviral vector based vaccines
US7069191B1 (en) * 2003-08-06 2006-06-27 Luminex Corporation Methods for reducing the susceptibility of a peak search to signal noise
ES2340038T3 (en) 2003-11-14 2010-05-28 Genvec, Inc. PHARMACEUTICAL COMPOSITION TO TREAT LOCALLY ADVANCED PANCREAS CANCER (CPLA) NOT REMOVABLE.
JP2007532656A (en) 2004-04-12 2007-11-15 アメリカ合衆国 Methods for inducing immune responses using adenoviral vectors
US7867707B2 (en) * 2004-06-11 2011-01-11 Evotec Ag Method for detecting analytes in a sample
WO2006039045A2 (en) * 2004-09-01 2006-04-13 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Adenoviral vectors able to transduce apcs, potential use in immune response generation
CN101080488A (en) * 2004-11-03 2007-11-28 因特罗根治疗公司 A new method for the production and purification of adenoviral vectors
US20060211075A1 (en) * 2005-03-02 2006-09-21 The Albert Einstein College Of Medicine Of Yeshiva University Enzyme sensors including environmentally sensitive or fluorescent labels and uses thereof
US9651543B2 (en) 2005-08-31 2017-05-16 The United States Of America As Represented By The Secretary Of The Navy Malaria antigen screening method
US8450055B2 (en) 2005-08-31 2013-05-28 The United States Of America As Represented By The Secretary Of The Navy Malaria antigen screening method
NZ542230A (en) * 2005-09-05 2008-05-30 Veritide Ltd System for spore detection
US7622723B2 (en) * 2005-09-23 2009-11-24 Veritide Limited System for spore detection
CA2629163C (en) * 2005-11-10 2017-03-21 Genvec, Inc. Adenoviral vector-based foot-and-mouth disease vaccine
US8454895B2 (en) * 2007-05-03 2013-06-04 Nanyang Technological University Online contaminant detection and removal system
US9605844B2 (en) * 2009-09-01 2017-03-28 Cree, Inc. Lighting device with heat dissipation elements
US9157921B2 (en) * 2011-05-18 2015-10-13 Purdue Research Foundation Method for diagnosing abnormality in tissue samples by combination of mass spectral and optical imaging
BR112017001601A2 (en) 2014-09-07 2017-11-21 Selecta Biosciences Inc methods and compositions for attenuating immune responses of the modulating antiviral transfer vector of gene expression
TWI710635B (en) 2014-10-09 2020-11-21 美商珍維克公司 Adenoviral vector encoding human atonal homolog-1 (hath1)
CN110325203A (en) 2017-01-07 2019-10-11 西莱克塔生物科技公司 Medelling with the immunosuppressor of synthesis nano-carrier coupling is administered
BR112020007157A2 (en) 2017-10-13 2020-09-24 Selecta Biosciences, Inc. methods and compositions for the attenuation of viral transfer anti-vector igm responses
CA3138525A1 (en) 2019-04-28 2020-11-05 Selecta Biosciences, Inc. Methods for treatment of subjects with preexisting immunity to viral transfer vectors
KR20220015425A (en) 2019-05-28 2022-02-08 셀렉타 바이오사이언시즈, 인크. Methods and compositions for attenuated antiviral transfer vector immune response
JP7769388B2 (en) 2019-12-12 2025-11-13 ティン セラピューティクス，インコーポレイテッド Compositions and methods for preventing and treating hearing loss
US20230141563A1 (en) 2021-10-12 2023-05-11 Selecta Biosciences, Inc. Methods and compositions for attenuating anti-viral transfer vector igm responses
WO2023172624A1 (en) 2022-03-09 2023-09-14 Selecta Biosciences, Inc. Immunosuppressants in combination with anti-igm agents and related dosing

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887812A (en) 1973-07-02 1975-06-03 Block Engineering Method and apparatus for detecting and classifying nucleic acid particles
US4222743A (en) 1978-07-20 1980-09-16 Wang Wei Kung Method and apparatus for detecting biological particles by fluorescent stain
WO1990013808A1 (en) 1989-05-01 1990-11-15 Byk Gulden Lomberg Chem Fab Reflection fluorimeter
US4979824A (en) 1989-05-26 1990-12-25 Board Of Trustees Of The Leland Stanford Junior University High sensitivity fluorescent single particle and single molecule detection apparatus and method
AU7162991A (en) 1989-12-12 1991-07-18 Lidak Pharmaceuticals Free fatty acid determination
DE69326967T2 (en) 1992-01-17 2000-06-15 Lakowicz, Joseph R. Phase modulation energy transfer fluoroimmunoassay
US5323008A (en) 1992-03-23 1994-06-21 Diatron Corporation Fluorometer detection system
US5733720A (en) 1992-06-18 1998-03-31 Washington University Genetically engineered cell lines for detecting infectious herpesvirus and methods therefor
AU4774093A (en) 1992-07-17 1994-02-14 Aprogenex, Inc. Free radical scavengers useful for reducing autofluorescence in fixed cells
US5733721A (en) 1992-11-20 1998-03-31 The Board Of Regents Of The University Of Oklahoma Cell analysis method using quantitative fluorescence image analysis
US5604096A (en) 1993-03-04 1997-02-18 Schaeffer; Warren I. Fluorometric quantitation of mycoplasmas
EP0655091A1 (en) 1993-05-06 1995-05-31 Baxter Diagnostics Inc. Human papillomavirus detection assay
US5421339A (en) 1993-05-12 1995-06-06 Board Of Regents, The University Of Texas System Diagnosis of dysplasia using laser induced fluoroescence
US5837520A (en) 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
US5895922A (en) 1996-03-19 1999-04-20 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Fluorescent biological particle detection system
JPH09262099A (en) 1996-03-28 1997-10-07 Aisin Seiki Co Ltd Method for detecting nucleic acid etc. by fluorescein derivative phosphate ester
TW371617B (en) 1996-10-09 1999-10-11 Of Animal And Plant Health Inspection And Quarantine Council Of Agriculture Executive Yuan Bureau Method to transplant GFP into autographa californica multiple nuclear polyhedrosis virus for inflicting pest in an attempt to detect and flow up it existence and to improve life span against UV
US6130313A (en) 1997-10-02 2000-10-10 Clontech Laboratories, Inc. Rapidly degrading GFP-fusion proteins
US5922576A (en) 1998-02-27 1999-07-13 The John Hopkins University Simplified system for generating recombinant adenoviruses
AU754999B2 (en) 1998-03-10 2002-11-28 Large Scale Proteomics Corporation Detection and characterization of microorganisms
US6265151B1 (en) 1998-03-27 2001-07-24 Seroptix, Inc. Apparatus and method for infectious disease detection
EE200000605A (en) 1998-04-22 2002-04-15 Genvec, Inc. Effective purification of the adenovirus
AU4188599A (en) 1998-05-15 1999-12-06 Geron Corporation Method and apparatus for detecting hazardous agents
GB9816761D0 (en) 1998-07-31 1998-09-30 Phogen Limited Herpesvirus preparations and their uses
JP2002542453A (en) 1998-08-08 2002-12-10 インペリアル キャンサー リサーチ テクノロジー リミテッド Fluorescence analysis of biological systems
US5965358A (en) 1998-08-26 1999-10-12 Genvec, Inc. Method for assessing the relative purity of viral gene transfer vector stocks
CA2252972C (en) 1998-11-26 2012-09-18 National Research Council Of Canada Serum-free production of recombinant proteins and adenoviral vectors
CZ20012428A3 (en) 1998-12-31 2001-11-14 Aventis Pharma S. A. Separation method of viral particles

Also Published As

Publication number Publication date
US6630299B2 (en) 2003-10-07
EP1322938A2 (en) 2003-07-02
WO2002029388A3 (en) 2002-12-27
US6447995B1 (en) 2002-09-10
US20020045160A1 (en) 2002-04-18
WO2002029388A2 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
AU2001296554A1 (en) Fluorescence detection
AU2002225807A1 (en) Object detection
AU2001293998A1 (en) Detection system
AU2001294989A1 (en) Speech detection
AU2001262847A1 (en) Language-understanding
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001220246A1 (en) Neckphone
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001258349A1 (en) Bisacylguanidine
AU2001272762A1 (en) Photomultiplier
AU2001272764A1 (en) Photomultiplier
AU2001281633A1 (en) Detection method
AU2001283890A1 (en) Window detection
AU2001258924A1 (en) Microsatellite-aflp
AUPQ667800A0 (en) Detection method
AUPR050700A0 (en) Detection method
AU2001272763A1 (en) Photomultiplier
AUPQ664300A0 (en) Macromolecule detection
AU2001232041A1 (en) Improved assay
AU2001246864A1 (en) Hypotensors
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001292922A1 (en) Nucleic acid detection
AU2001262711A1 (en) Cytoprotectors
AU2001287754A1 (en) Impactor